News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Friday, December 19, 2014

Top Breaking News

Featured Stories
Ibuprofen May Be The Key To Anti-Aging, Buck Institute for Age Research Study
Scientists Slam The Caveman Diet, Georgia State University Study
The Ebola Treatment You Know Nothing About
Fifty Three Approved Drugs That May Block Ebola Infection, Mount Sinai Hospital Study
Tooth Loss Linked To Slowing Mind And Body, University College London Study
Bilberries May Counter Adverse Effects Of High-Fat Diets, University Of Eastern Finland Study
Standing On One Leg For 20 Seconds May Predict Stroke Risk, Kyoto University Study
Not Again! First Ever Case Of Anxiety-Induced Deja Vu, Sheffield Hallam University Study
OTC Painkillers Linked To Reduced Skin Cancer Risk, University of London Study
Low-Dose Lithium Prevents Parkinson's Symptoms In Aged Mice With A Human Mutation For The Disease, Buck Institute for Age Research Study
Most Commonly Prescribed Glaucoma Drug Reduces Risk Of Vision Loss By More Than 50% Over 2 Years: Lancet
Drug Developed Proves Effective Against Antibiotic-Resistant "Superbugs," University of Pittsburgh Study

More News
Alcon Laboratories, Inc. (ACL) Release: FDA Approves Xtoro To Treat Swimmer's Ear
Vernalis PLC (VNLPY.PK): Update On AUY922 Development Programme
Orexigen Therapeutics, Inc. (OREX)'s Mysimba (Naltrexone Hcl / Bupropion Hcl Prolonged Release) Receives Positive CHMP Opinion Recommending Approval For Weight Management In The European Union
Celgene (CELG) Receives Positive CHMP Opinion To Extend REVLIMID® (Lenalidomide) For Continuous Use In Patients With Newly Diagnosed Multiple Myeloma And Ineligible For Transplant
Cardio3 BioSciences Announces The Enrolment Of The 240th Patient For Its CHART-1 Phase 3 Clinical Trial For The Treatment Of Heart Failure
Roche (RHHBY) Provides Update On Gantenerumab Development Programme
Genentech (RHHBY) Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer
Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Receives Orphan Drug Designation In The United States And The European Union For The Treatment Of Malignant Pleural Mesothelioma
AB Science (AB.PA): Report Of Positive Clinical Study Data In Metastatic Colorectal Cancer
Innate Pharma (IPH.PA ): First Phase 2 Trial With IPH2201 Open In Head And Neck Cancer
Amarantus BioSciences, Inc. Submits Orphan Drug Designation Application To U.S. FDA For Treatment Of Retinal Artery Occlusion With Product Candidate MANF
Halozyme Therapeutics, Inc. (HALO) Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Results From The Phase 2 Borealis-1 Trial Of Apatorsen In The Treatment Of Metastatic Bladder Cancer
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I
Aratana Therapeutics (PETX) Announces Positive Top-Line Results From AT-001 Pivotal Field Study In Client-Owned Dogs With Osteoarthritis
Three SomaGenics Inc. Publications Demonstrate Successful Inhibition Of The Hepatitis C Virus By Therapeutic sshRNA And Confirm Mechanism Of Action
St. Jude Children's Research Hospital Release: Cells Identified That Enhance Tumor Growth And Suppress Anti-Cancer Immune Attack
Canopus BioPharma, Inc. Announces Positive Results From An In-Vitro Live Ebola Virus Study
A*STAR Scientists Discover Gene Critical For Proper Brain Development
Merck & Co. (MRK) Begins Tender Offer To Acquire Cubist Pharmaceuticals, Inc. (CBST)
Roche (RHHBY) Acquires Bina Technologies And Enters The Genomic Informatics Market
Achievement Of Multiple Milestones In Evotec AG (EVTG.F)'s Drug Discovery Alliances
RXi Pharmaceuticals (RXII) Expands Its Clinical Pipeline With An Exclusive Global License For A Second Phase 2 Clinical Compound
Sorrento Therapeutics, Inc. And Announce Exclusive Global Collaboration
PreventionGenetics LLC Teams Up With Seattle Children's Hospital PLUGS Program To Enhance Utilization Management
Harbour Antibodies Announces First U.S. Patent For Novel Transgenic Mouse Antibody Technology For Next Generation Therapeutic Antibody Discovery
Amarantus BioSciences, Inc. Announces Second Closing Of Series E Preferred Financing
Nymox Pharmaceutical (NYMX) Announces $1.07 Million Financing
Soligenix (SNGX) Announces Pricing Of Public Offering Of Units
PlasmaTech Biopharmaceuticals Announces Pricing Of $14,000,000 Public Offering And Listing On NASDAQ
Novogen Limited (NVGN) Raises An Additional A$1.75m In Private Placement To US Institutions For Aggregate Private Placement Of A$5.85m
Alzheimer's Drug Discovery Foundation Release: US Nonprofit Awards Italian Biotech Additional Funding To Study New Class Of Drugs To Treat Alzheimer's Disease
AEterna Zentaris (AEZS) Receives Notification From NASDAQ Relating To Minimum Bid Price
ABIVAX, A Privileged Partner Of The Cuban Life Science Industry, Welcomes Initiative To Renew Relations Between The USA And Cuba
Hyperion Therapeutics (HPTX) Added To Nasdaq Biotechnology Index (NBI)
Relmada Therapeutics Announces Results Of Annual Shareholders Meeting
Nasdaq Welcomes Bellicum Pharmaceuticals, Inc. To The Nasdaq Stock Market
Baptist Health Lexington First In The Nation To Receive Atrial Fibrillation With EPS Accreditation
Newron Pharmaceuticals (NWRN) Release: CHMP Recommends Approval Of Xadago (Safinamide) To Treat Parkinson´s Disease In The EU
CAPNIA, Inc. Reports Third Quarter 2014 Financial Results
Ohr Pharmaceutical (OHRP) To Announce Fiscal 2014 Financial Results And Host Conference Call On Monday, December 22
Dr. Tanya Mayadas Joins Biothera's Research Advisory Board
New Chairman Appointed At Egenix, Inc.
Tekmira (TKMR) Pharmaceuticals Announces Leadership Changes
Veloxis Pharmaceuticals A/S (VELO) Comments On U.S. District Court Order
AmVac AG Release: New Possibilities In The Fight Against Pancreatic Cancer
DuPont (DD) CEO Discusses Competitive Imperative Of A Total Innovation System At The Council On Foreign Relations
Flu Season Has Arrived, Says TriCore Reference Laboratories
Premune Joins Leaders In Healthcare Innovation At 2015 OneMedforum
Actavis (ACT) To Present At The Goldman, Sachs & Co. Healthcare CEOs Unscripted Conference
Record-Setting Utah Life Science Summit Caps Highly Successful 2014 For BioUtah
Intellia Therapeutics To Present At Biotech Showcase 2015
Cytori Therapeutics, Inc. (CYTX) To Host An Informational Session On Its Planned U.S. STAR Pivotal Trial With Principal Investigator, Dr. Dinesh Khanna
McKesson Corporation To Present At The 33rd Annual J.P. Morgan Healthcare Conference
Baxter International, Inc. (BAX) To Present At 33rd Annual J.P. Morgan Healthcare Conference
Naurex Inc. To Present At 33rd Annual J.P. Morgan Healthcare Conference
Akorn, Inc. (AKN) To Present At The 33rd Annual J.P. Morgan Healthcare Conference